Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Arbor Biotechnologies
Lilly hopes to address immunology and pain indications with biotech’s LYTAC technology. Sunovion licenses European rights to Parkinson’s therapy Kynmobi to Bial.
Following a strategic review, AMAG goes to Covis. Vincera goes public in merger with blank check company, has pending cancer deal with Bayer.
- Gene Therapy, Cell Therapy
- Other Names / Subsidiaries